Clinical Trial

A Study of TYK-00540 in Adult Patients With Solid Tumors

Name: A Study of TYK-00540 in Adult Patients With Solid Tumors — clinical trial record (NCT06246071)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Study acronym: ASOTIAPWST

Recruiting Phase 1

View on ClinicalTrials.gov →

Summary

The primary objective of this study is to evaluate the safety and tolerability of TYK-00540, with dose-escalation stage and dose-expansion stage.

Trial Details

NCT Number	NCT06246071
Lead Sponsor	TYK Medicines, Inc
Conditions	Locally Advanced or Metastatic Solid Tumors
Enrollment	156 participants
Start Date	2024-01-02
Primary Completion	2026-12-05 (estimated)
Study Completion	2026-12-05 (estimated)
Updated on ClinicalTrials.gov	2024-02-07